Similar articles

• In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

  Livermore DM, Williams JD. Livermore DM, et al. J Antimicrob Chemother. 1981 Dec;8 Suppl E:29-37. doi: 10.1093/jac/8.suppl_e.29. J Antimicrob Chemother. 1981. PMID: 6799480 No abstract available.
• Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.

  Reeves DS, Bywater MJ, Holt HA. Reeves DS, et al. J Antimicrob Chemother. 1981 Dec;8 Suppl E:57-68. doi: 10.1093/jac/8.suppl_e.57. J Antimicrob Chemother. 1981. PMID: 6799483 No abstract available.
• Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

  Neu HC, Labthavikul P. Neu HC, et al. J Antimicrob Chemother. 1981 Dec;8 Suppl E:111-22. doi: 10.1093/jac/8.suppl_e.111. J Antimicrob Chemother. 1981. PMID: 6799479 No abstract available.
• Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.

  Dudley MN, Ambrose PG, Bhavnani SM, Craig WA, Ferraro MJ, Jones RN; Antimicrobial Susceptibility Testing Subcommittee of the Clinical and Laboratory Standards Institute. Dudley MN, et al. Clin Infect Dis. 2013 May;56(9):1301-9. doi: 10.1093/cid/cit017. Epub 2013 Jan 18. Clin Infect Dis. 2013. PMID: 23334813 Review.
• Beta-lactamase induction and resistance to beta-lactam antibiotics.

  Rolinson GN. Rolinson GN. J Antimicrob Chemother. 1989 Jan;23(1):1-2. doi: 10.1093/jac/23.1.1. J Antimicrob Chemother. 1989. PMID: 2501264 Review. No abstract available.